By focusing on risk, companies avoid "over-validating" low-impact systems, allowing them to bring new technologies online faster.
Following GAMP® guidelines significantly improves readiness for audits by the FDA, EMA, and other global health authorities. gamp ispe
Will the software affect the efficacy or purity of the drug? By focusing on risk
Not every system requires the same level of scrutiny. GAMP 5 advocates for scaling validation efforts based on: companies avoid "over-validating" low-impact systems
Implementing GAMP and ISPE guidelines provides numerous benefits, including:
The primary objective remains consistent: to encourage the creation of effective, reliable, and high-quality computerized systems through a cost-effective and efficient framework . The Core Principle: A Risk-Based Approach
Navigating GAMP® 5: The ISPE Framework for Risk-Based Compliance